Sumitomo Mitsui Financial Group, Inc. (LON:0LAF)
19.36
+0.30 (1.57%)
At close: Dec 19, 2025
LON:0LAF Revenue
Sumitomo Mitsui Financial Group had revenue of 654.99B JPY in the quarter ending June 30, 2025, a decrease of -15.78%. This brings the company's revenue in the last twelve months to -280.76B. In the fiscal year ending March 31, 2025, Sumitomo Mitsui Financial Group had annual revenue of 3.43T, down -8.27%.
Revenue (ttm)
-280.76B JPY
Revenue Growth
-8.27%
P/S Ratio
5.32
Revenue / Employee
-2.28M JPY
Employees
123,000
Market Cap
91.52B GBP
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.43T | -309.25B | -8.27% |
| Mar 31, 2024 | 3.74T | 99.67B | 2.74% |
| Mar 31, 2023 | 3.64T | 780.99B | 27.33% |
| Mar 31, 2022 | 2.86T | -25.62B | -0.89% |
| Mar 31, 2021 | 2.88T | 439.19B | 17.97% |
| Mar 31, 2020 | 2.44T | -603.29B | -19.80% |
| Mar 31, 2019 | 3.05T | -590.40B | -16.23% |
| Mar 31, 2018 | 3.64T | 502.67B | 16.03% |
| Mar 31, 2017 | 3.13T | -404.94B | -11.44% |
| Mar 31, 2016 | 3.54T | 297.58B | 9.18% |
| Mar 31, 2015 | 3.24T | 3.67B | 0.11% |
| Mar 31, 2014 | 3.24T | 614.09B | 23.40% |
| Mar 31, 2013 | 2.62T | 74.35B | 2.92% |
| Mar 31, 2012 | 2.55T | 105.88B | 4.33% |
| Mar 31, 2011 | 2.44T | -61.60B | -2.46% |
| Mar 31, 2010 | 2.51T | 1.34T | 114.11% |
| Mar 31, 2009 | 1.17T | -2,537.55B | -68.44% |
| Mar 31, 2008 | 3.71T | 1.84T | 98.46% |
| Mar 31, 2007 | 1.87T | -179.12B | -8.75% |
| Mar 31, 2006 | 2.05T | 61.96B | 3.12% |
| Mar 31, 2005 | 1.99T | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |